According to PR Newswire, OpenAI's GPT-5 has achieved a breakthrough in the field of biomanufacturing. The closed-loop automated system developed in collaboration with Ginkgo Bioworks has reduced the cost of cell-free protein synthesis by approximately 40% and cut reagent costs by 57%.
